MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from exercised
stock options
$446K
Net cash provided by
financing activities
$446K
Net decrease in cash
and cash...
-$4,941K
Canceled cashflow
$446K
Stock-based compensation
$6,243K
Accounts receivable, net
-$3,948K
Accounts payable
$3,654K
Other current assets
-$338K
Depreciation and
amortization
$124K
Net cash used in
operating activities
-$5,260K
Canceled cashflow
$14,307K
Net cash used in
investing activities
-$127K
Net loss
-$8,436K
Accrued liabilities and
other
-$4,376K
Foreign currency
transactions
$2,752K
Inventories
$2,394K
Inventories, long-term
$1,451K
Other assets
$158K
Purchase of property and
equipment
$127K
Back
Back
Cash Flow
source: myfinsight.com
Y-mAbs Therapeutics, Inc. (YMAB)
Y-mAbs Therapeutics, Inc. (YMAB)